Many have argued that health care reform in the US is a significant threat to pharma, largely due to the expectation that health care reform will certainly equate to some form of price control by the government that will dramatically reduce reimbursement for pharma products.  For many years, the public has railed over the price [...]

Fixing Pharma.   For years, perhaps for decades, the doom and gloom about pharma’s decline has always lurked just around the corner…price controls, me-too products, and unsustainable healthcare costs always threatened.   For those of us who have been in the trenches seeking the holy grail… a robust pipeline, that is… there has always been another [...]